Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trialP J Loehrer, S Turner, P Kubilis, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 31, 1997
Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplastyJ F Price, N Mamode, F B Smith, et al.Journal of Vascular Surgery|April 18, 1998
The value of computed tomography in the assessment of suspected ruptured abdominal aortic aneurysmD J Adam, A W Bradbury, W P Stuart, et al.Breast Cancer Research and Treatment|January 1, 1996
Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolinesA E Wakeling, A J Barker, D H Davies, et al.Cancer Research|October 18, 2002
ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapyAlan E Wakeling, Simon P Guy, Jim R Woodburn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancerL H Einhorn, P J Loehrer, S D Williams, et al.Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancerA J Barker, K H Gibson, W Grundy, et al.Pageof 4